Role of prostaglandin signaling in the control of glucose homeostasis
Project/Area Number |
15K08230
|
Research Category |
Grant-in-Aid for Scientific Research (C)
|
Allocation Type | Multi-year Fund |
Section | 一般 |
Research Field |
General pharmacology
|
Research Institution | Kyoto University |
Principal Investigator |
|
Co-Investigator(Kenkyū-buntansha) |
南 学 京都大学, 医学研究科, 准教授 (90511907)
|
Co-Investigator(Renkei-kenkyūsha) |
KAMEI Kaeko 京都工芸繊維大学, 工芸科学研究科, 教授 (00214544)
|
Project Period (FY) |
2015-04-01 – 2018-03-31
|
Project Status |
Completed (Fiscal Year 2017)
|
Budget Amount *help |
¥4,940,000 (Direct Cost: ¥3,800,000、Indirect Cost: ¥1,140,000)
Fiscal Year 2017: ¥1,040,000 (Direct Cost: ¥800,000、Indirect Cost: ¥240,000)
Fiscal Year 2016: ¥1,950,000 (Direct Cost: ¥1,500,000、Indirect Cost: ¥450,000)
Fiscal Year 2015: ¥1,950,000 (Direct Cost: ¥1,500,000、Indirect Cost: ¥450,000)
|
Keywords | プロスタグランジン / マクロファージ / 慢性炎症 / 糖代謝 |
Outline of Final Research Achievements |
With increasing body weight, macrophages accumulate in adipose tissue, giving rise to chronic inflammation and insulin resistance. In this study, we treated db/db mice with a prostaglandin E2 type 4 receptor (EP4) -selective agonist to explore the role of EP4 signaling in obesity-related inflammation. In the EP4 agonist-treated group, glucose tolerance and insulin resistance were significantly improved. Administration of the EP4 agonist inhibited the accumulation of F4/80-positive macrophages and the formation of crown-like structures, but increased the number of anti-inflammatory M2 macrophages in adipose tissue. In vitro M1/M2 polarization assay showed that treatment with EP4 agonist enhanced M2 polarization in wild-type peritoneal macrophages, whereas EP4-deficient macrophages were less susceptible to M2 polarization. Thus, EP4 signaling plays a critical role in obesity-related adipose tissue inflammation by regulating macrophage recruitment and polarization.
|
Report
(4 results)
Research Products
(17 results)
-
-
-
-
-
-
[Journal Article] Safety and Anti-tumor Activity of Anti–PD-1 Antibody (Nivolumab: ONO-4538/BMS-936558) in Patients with Platinum-resistant Ovarian Cancer.2015
Author(s)
Hamanishi, J., M. Mandai, T. Ikeda, M. Minami, A. Kawaguchi, T. Murayama, M. Kanai, Y. Mori, S. Matsumoto, S. Chikuma, N. Matsumura, K. Abiko, T. Baba, K. Yamaguchi, A. Ueda, Y. Hosoe, S. Morita, M. Yokode, A. Shimizu, T. Honjo, I. Konishi.
-
Journal Title
J Clin Oncol
Volume: 33
Issue: 34
Pages: 4015-22
DOI
Related Report
Peer Reviewed / Open Access
-
[Journal Article] The Prostaglandin E2 Receptor EP4 Regulates Obesity-related Inflammation and Insulin Sensitivity.2015
Author(s)
Yasui, M., Y. Tamura, M. Minami*, S. Higuchi, R. Fujikawa, T. Ikedo, M. Nagata, H. Arai, T. Murayama, and M. Yokode.
-
Journal Title
PLoS One
Volume: 10
Issue: 8
Pages: e0136304-e0136304
DOI
NAID
Related Report
Peer Reviewed / Open Access / Acknowledgement Compliant
-
[Journal Article] EP4 receptor–associated protein in macrophages ameliorates colitis and colitis-associated tumorigenesis.2015
Author(s)
Nakatsuji, M., M. Minami*, H. Seno*, M. Yasui, H. Komekado, S. Higuchi, R. Fujikawa, Y. Nakanishi, A. Fukuda, K. Kawada, Y. Sakai, T. Kita, P. Libby, H. Ikeuchi, M. Yokode, and T. Chiba
-
Journal Title
PLoS Genet
Volume: 11
Issue: 10
Pages: e1005542-e1005542
DOI
NAID
Related Report
Peer Reviewed / Open Access / Int'l Joint Research / Acknowledgement Compliant
-
-
-
-
-
-
-
-
-